Published on 29 Aug 2022 on Zacks via Yahoo Finance
Vigil Neuroscience, Inc. (VIGL) closed the last trading session at $8.38, gaining 26% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19.50 indicates a 132.7% upside potential.
The average comprises four short-term price targets ranging from a low of $11 to a high of $24, with a standard deviation of $5.92. While the lowest estimate indicates an increase of 31.3% from the current price level, the most optimistic estimate points to an 186.4% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.
While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.